Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet alpha2-macroglobulin and alpha1-antitrypsin.

R L Nachman, P C Harpel

    The Journal of Biological Chemistry
    |August 10, 1976
    PubMed
    Summary

    Human platelets contain alpha2-macroglobulin and alpha1-antitrypsin protease inhibitors. These platelet proteins are immunologically similar to plasma versions and may influence clot formation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The Jeremiah Metzger Lecture. Hypercoagulable states: challenges and opportunities.

    Transactions of the American Clinical and Climatological Association·2001
    Same author

    The chemokine receptor CCR8 mediates human endothelial cell chemotaxis induced by I-309 and Kaposi sarcoma herpesvirus-encoded vMIP-I and by lipoprotein(a)-stimulated endothelial cell conditioned medium.

    Blood·2001
    Same author

    Histidine-rich glycoprotein inhibits the antiangiogenic effect of thrombospondin-1.

    The Journal of clinical investigation·2001
    Same author

    CC chemokine I-309 is the principal monocyte chemoattractant induced by apolipoprotein(a) in human vascular endothelial cells.

    Circulation·2000
    Same author

    Angiogenesis and atherosclerosis. The mandate broadens.

    Circulation·1999
    Same author

    Dose response of intravenous heparin on markers of thrombosis during primary total hip replacement.

    Anesthesiology·1999

    Area of Science:

    • Biochemistry
    • Hematology
    • Cell Biology

    Background:

    • Platelets play a crucial role in hemostasis and thrombosis.
    • Protease inhibitors are essential for regulating enzymatic activity.
    • The presence and function of protease inhibitors within platelets were not fully understood.

    Purpose of the Study:

    • To identify and characterize alpha2-macroglobulin and alpha1-antitrypsin in human platelets.
    • To investigate the functional activity of these platelet-derived protease inhibitors.
    • To explore the potential role of platelet protease inhibitors in hemostasis.

    Main Methods:

    • Subcellular fractionation of human platelets (membrane and granule fractions).
    • Immunological identification using antibody-based assays.
    • Analysis of protein structure via SDS-PAGE.
    • Functional assays using radiolabeled trypsin binding.

    Main Results:

    • Immunologically identical alpha2-macroglobulin and alpha1-antitrypsin were detected in platelet subcellular fractions.
    • Platelet protease inhibitors exhibited similar subunit polypeptide structures to plasma counterparts.
    • Granule-associated and membrane-associated alpha2-macroglobulin, and granule-associated alpha1-antitrypsin were found to be functionally active.
    • Platelets contain lower concentrations of these inhibitors compared to fibrinogen and Factor VIII.

    Conclusions:

    • Human platelets contain functionally active alpha2-macroglobulin and alpha1-antitrypsin.
    • These platelet protease inhibitors share immunological and structural similarities with plasma proteins.
    • Platelet protease inhibitors may play a role in modulating protease-mediated events during hemostasis and thrombus formation.

    Related Experiment Videos